Literature DB >> 18035482

Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1.

Yunwei Sun1, Liang Qiao, Harry Hua-Xiang Xia, Marie C M Lin, Bing Zou, Yaozong Yuan, Senlin Zhu, Qing Gu, Ting Kin Cheung, Hsiang Fu Kung, Man Fung Yuen, Annie Oo Chan, Benjamin C Y Wong.   

Abstract

XIAP-associated factor 1 (XAF1) is a novel tumor suppressor and interferon stimulated gene (ISG). Interferon beta (IFNbeta) exerts anti-proliferative effect and induces apoptosis through the Jak-Stat signaling cascade by the type I Interferon receptor (IFN-R), which initiates gene transcription of those biological effectors of IFNbeta. The aim of this study is to determine the effect of IFNbeta on XAF1 expression and the putative mechanisms mediated by the critical role of signal transducers and activators of transcription 1 (Stat1). Gene expression was detected by RT-PCR and Western blot analysis. The promoter activity of XAF1 was examined by luciferase reporter assay. The activity of interferon stimulated response element (ISRE) was assessed by electrophoretic mobility shift assay (EMSA) and quantitative chromatin immunoprecipitation assay (Q-ChIP). Results showed that IFNbeta stimulated XAF1 promoter activity in colon cancer cell line DLD1 in a time- and dose-dependent manner. A high affinity ISRE binding element (ISRE-XAF1) was located in -55 to -66 nt upstream of the first ATG site of XAF1 gene. Deletion of ISRE-XAF1 completely abrogated basal and IFNbeta-induced promoter activity. IFNbeta-induced XAF1 expression was mediated by Stat1 through the interaction with ISRE-XAF1. Knocking down of the Stat1 expression and blocking its phosphorylation decreased IFNbeta-induced XAF1 expression. Results suggested that induction of an immediate early response gene-XAF1 by IFNbeta was mediated by the transcription regulator Stat1 through the ISRE site within the promoter region of XAF1 gene in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035482     DOI: 10.1016/j.canlet.2007.10.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin.

Authors:  Wen-Cui Ju; Guo-Bin Huang; Xiao-Yong Luo; Wei-Hua Ren; De-Qing Zheng; Pin-Jia Chen; Yun-Feng Lou; Bin Li
Journal:  Med Oncol       Date:  2014-11-01       Impact factor: 3.064

2.  Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance.

Authors:  J-E Lee; H-Y Nam; S-M Shim; G-R Bae; B-G Han; J-P Jeon
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

3.  Assessment of XAF1 as A Biomarker to Differentiate Hepatocellular Carcinoma from Nonneoplastic Liver Tissues.

Authors:  Ying Lin; Wei Li
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

4.  XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells.

Authors:  Zhaoquan Xing; Zunlin Zhou; Rong Yu; Shuling Li; Chunde Li; Sten Nilsson; Zhaoxu Liu
Journal:  J Exp Clin Cancer Res       Date:  2010-12-11

5.  Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data.

Authors:  Andrew E Dellinger; Andrew B Nixon; Herbert Pang
Journal:  Cancer Inform       Date:  2014-07-28

6.  Embryonic periventricular endothelial cells demonstrate a unique pro-neurodevelopment and anti-inflammatory gene signature.

Authors:  Franciele Cristina Kipper; Cleide Angolano; Ravi Vissapragada; Mauricio A Contreras; Justin Moore; Manoj Bhasin; Christiane Ferran; Ajith J Thomas
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

7.  MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy.

Authors:  Marina Juraleviciute; Jérémie Nsengimana; Julia Newton-Bishop; Gert J Hendriks; Ana Slipicevic
Journal:  Cancer Med       Date:  2021-03-18       Impact factor: 4.452

8.  Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection.

Authors:  Kami Pekayvaz; Alexander Leunig; Rainer Kaiser; Markus Joppich; Sophia Brambs; Aleksandar Janjic; Oliver Popp; Daniel Nixdorf; Valeria Fumagalli; Nora Schmidt; Vivien Polewka; Afra Anjum; Viktoria Knottenberg; Luke Eivers; Lucas E Wange; Christoph Gold; Marieluise Kirchner; Maximilian Muenchhoff; Johannes C Hellmuth; Clemens Scherer; Raquel Rubio-Acero; Tabea Eser; Flora Deák; Kerstin Puchinger; Niklas Kuhl; Andreas Linder; Kathrin Saar; Lukas Tomas; Christian Schulz; Andreas Wieser; Wolfgang Enard; Inge Kroidl; Christof Geldmacher; Michael von Bergwelt-Baildon; Oliver T Keppler; Mathias Munschauer; Matteo Iannacone; Ralf Zimmer; Philipp Mertins; Norbert Hubner; Michael Hoelscher; Steffen Massberg; Konstantin Stark; Leo Nicolai
Journal:  Nat Commun       Date:  2022-02-23       Impact factor: 17.694

9.  Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.

Authors:  Georgina Victoria-Acosta; Karla Vazquez-Santillan; Luis Jimenez-Hernandez; Laura Muñoz-Galindo; Vilma Maldonado; Gustavo Ulises Martinez-Ruiz; Jorge Melendez-Zajgla
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

Review 10.  "Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway.

Authors:  Emira Bousoik; Hamidreza Montazeri Aliabadi
Journal:  Front Oncol       Date:  2018-07-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.